Trial Profile
A study comparing Dihydroartemisinin-piperaquine with artesunate-amodiaquine for treatment of malaria infection in pregnancy in Ghana.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 04 Sep 2017
Price :
$35
*
At a glance
- Drugs Dihydroartemisinin/piperaquine (Primary) ; Artesunate/amodiaquine
- Indications Malaria
- Focus Therapeutic Use
- 04 Sep 2017 New trial record
- 01 Aug 2017 Primary endpoint (Parasitological efficacy (PE)) has been met as per the results published in the Tropical Medicine and International Health
- 01 Aug 2017 Results published in the Tropical Medicine and International Health